PARTNER INTERVIEW: DeepIntent
Agentic AI: The Next Evolution of Healthcare Marketing
In this Partner Interview, DeepIntent CMO Ian Colley joins solli’s Rich Springham to explore the rise of agentic AI and what it could mean for healthcare marketers, from faster planning and audience development to more intelligent campaign activation and optimisation.
As pharmaceutical marketing becomes increasingly data-rich and complex, Colley argues that agentic AI can help marketers make sense of disparate datasets and support better decision-making. The conversation explores DeepIntent’s Cora platform, the importance of trusted data, and how conversational interfaces could make sophisticated healthcare data more accessible while keeping human oversight central.
Looking ahead, Colley sees agentic AI as potentially transformational, helping organisations break down silos, accelerate data driven marketing and improve the commercial viability of treatments for increasingly specific patient populations.
The opportunity, he says, lies in combining speed and automation with trust, collaboration and rigorous data foundations.
